ArticleOphthalmology science2026

MyopiaX-1 Safety and Efficacy of a Novel Approach to Slow Juvenile Myopia Progression: A Multicenter, Randomized, Controlled Trial.

James Loughman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.